Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LMNA | P02545 | 2/20 | 0.89 |
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.46 |
| ▸ | MMP1 | P03956 | 1/20 | 0.46 |
| ▸ | MMP2 | P08253 | 1/20 | 0.46 |
| ▸ | MMP3 | P08254 | 1/20 | 0.46 |
| ▸ | MMP8 | P22894 | 1/20 | 0.46 |
| ▸ | NPC1 | O15118 | 2/20 | 0.43 |
| ▸ | TSHR | P16473 | 2/20 | 0.43 |
| ▸ | HPGD | P15428 | 2/20 | 0.43 |
| ▸ | RAB9A | P51151 | 1/20 | 0.43 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.43 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.41 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.41 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.41 |
| ▸ | KDM5A | P29375 | 1/20 | 0.39 |
| ▸ | KDM4C | Q9H3R0 | 1/20 | 0.39 |
| ▸ | CA12 | O43570 | 1/20 | 0.39 |
| ▸ | CA1 | P00915 | 1/20 | 0.39 |
| ▸ | CA9 | Q16790 | 1/20 | 0.39 |
| ▸ | CES2 | O00748 | 2/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL13630657 | 0.97 | LMNA (0.84) | LMNAALDH1A1MMP1MMP2MMP3 | |
| SCHEMBL2479243 | 0.92 | LMNA (0.76) | LMNAALDH1A1TSHRALOX15HSD17B10 | |
| SCHEMBL782025 | 0.90 | LMNA (0.73) | LMNAALDH1A1TSHRALOX15HSD17B10 | |
| SCHEMBL781111 | 0.90 | LMNA (0.73) | LMNAALDH1A1TSHRALOX15HSD17B10 | |
| SCHEMBL780994 | 0.90 | LMNA (0.73) | LMNAALDH1A1TSHRALOX15HSD17B10 | |
| SCHEMBL23646903 | 0.90 | LMNA (0.73) | LMNAALDH1A1TSHRALOX15HSD17B10 | |
| SCHEMBL6117074 | 0.90 | LMNA (0.73) | LMNAALDH1A1TSHRALOX15HSD17B10 | |
| SCHEMBL79816 | 0.90 | LMNA (0.73) | LMNAALDH1A1TSHRALOX15HSD17B10 | |
| N,N-Diethylstearamide SCHEMBL738376 | 0.90 | LMNA (0.73) | LMNAALDH1A1TSHRALOX15HSD17B10 | |
| SCHEMBL9570178 | 0.90 | LMNA (0.73) | LMNAALDH1A1MMP1MMP2MMP3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2102148-B1 | NOVEL BIS(DIALKYLAMIDE) COMPOUNDS, PROCESS FOR THE PREPARATION THEREOF AND USES THEREOF | RHODIA OPERATIONS (FR) | 2015-09-16 | — | — | EP | disclosed |
| US-8580712-B2 | Bis(dialkylamide) compounds and diverse applications thereof | RHODIA OPERATIONS (FR) | 2013-11-12 | — | — | US | disclosed |
| US-20130222720-A1 | METHOD FOR MANUFACTURING LIQUID CRYSTAL DISPLAY DEVICE PROVIDED WITH FRONT PLATE, AND LIQUID CRYSTAL DISPLAY DEVICE PROVIDED WITH FRONT PLATE | KONICA MINOLTA , INC. (JP) | 2013-08-29 | — | — | US | disclosed |
| US-8502937-B2 | Protective film for polarizers | FUJIFILM CORPORATION (JP) | 2013-08-06 | — | — | US | disclosed |
| US-20100113279-A1 | NOVEL BIS(DIALKYLAMIDE) COMPOUNDS AND DIVERSE APPLICATIONS THEREOF | SPECIALTY OPERATIONS FRANCE (FR) | 2010-05-06 | — | — | US | disclosed |
| EP-2102148-A1 | NOVEL BIS(DIALKYLAMIDE) COMPOUNDS, PROCESS FOR THE PREPARATION THEREOF AND USES THEREOF | Rhodia Opérations (FR) | 2009-09-23 | — | — | EP | disclosed |
| WO-2008074837-A1 | NOVEL BIS(DIALKYLAMIDE) COMPOUNDS, PROCESS FOR THE PREPARATION THEREOF AND USES THEREOF | RHODIA OPERATIONS (FR) | 2008-06-26 | — | — | WO | disclosed |
| US-20070259134-A1 | Cellulose Compound Film, Optical Compensation Sheet, Polarizing Plate, and Liquid Crystal Display Device | FUJIFILM CORPORATION (JP) | 2007-11-08 | — | — | US | disclosed |
| US-20070182895-A1 | Liquid crystal display device | FUJI PHOTO FILM CO., LTD. (JP) | 2007-08-09 | — | — | US | disclosed |
| CN-1405150-A | Protein modifier, preparation method and use thereof | PROCESS INST CHINESE ACADEMY O (CN) | 2003-03-26 | — | — | CN | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100113279-A1 | NOVEL BIS(DIALKYLAMIDE) COMPOUNDS AND DIVERSE APPLICATIONS THEREOF | C1R, CBR3, CWC15 | LMNA 187/4885ALDH1A1 3605/4885MMP1 4872/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.